Cysteine Protease Inhibitors in Malaria Parasite Biology

The malaria parasite Plasmodium spp. relies on a suite of cysteine proteases to degrade host haemoglobin, remodel cellular compartments and mediate host cell egress and invasion. Central to these processes are falcipains, a subfamily of papain-type enzymes that operate within the acidic food vacuole to liberate amino acids essential for parasite growth. Inhibitors that target falcipains—ranging from endogenous proteins such as falstatin and prodomains to synthetic small molecules—have demonstrated potent blockade of haemoglobin hydrolysis and parasite maturation. Advances in structural biology have revealed unique active-site conformations and allosteric pockets that can be exploited for selective drug design. By integrating biochemical assays, crystallography and computational chemistry, researchers are now able to fine-tune inhibitor potency and pharmacokinetics, marking cysteine protease inhibitors as leading candidates in the ongoing effort to overcome antimalarial resistance and achieve global malaria control.

Research from Nature Portfolio

Recent studies have employed structure-based virtual screening and molecular dynamics simulations to identify non-peptidic scaffolds capable of selectively inhibiting falcipain-2 and falcipain-3. A pioneering investigation used a South African natural compound library to discover a cholesterol-like steroid derivative that binds favourably to the haemoglobinase active site while sparing human cathepsins. Follow-up three-dimensional similarity searches within large chemical databases yielded additional hit compounds. Detailed molecular dynamics analyses highlighted key interactions—such as hydrogen bonds with the catalytic cysteine and π–π stacking with unique falcipain subsite residues—providing a rationale for the rational optimisation of these lead molecules towards improved potency and drug-like properties.

Cysteine Protease Inhibitors in Malaria Parasite Biology publication trend

The graph below shows the total number of articles in cysteine protease inhibitors in malaria parasite biology across all publications each year (not limited to Nature Index journals).

Technical terms

Cysteine protease: A class of enzymes that utilise a catalytic cysteine residue to cleave peptide bonds in proteins.

Falcipain: A family of papain-like cysteine proteases from Plasmodium falciparum, crucial for haemoglobin degradation.

Haemoglobinase: An enzyme that specifically cleaves host haemoglobin to release amino acids for parasite growth.

Zymogen: An inactive precursor of an enzyme, which requires proteolytic cleavage for activation.

Molecular docking: A computational technique used to predict the preferred orientation and binding affinity of a small molecule within an enzyme’s active site.

References

1. Roles of Cysteine Proteases in Biology and Pathogenesis of Parasites. Microorganisms (2023).
2. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs. Scientific Reports (2016).
3. Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets. Frontiers in Microbiology (2019).
4. Falstatin, a Cysteine Protease Inhibitor of Plasmodium falciparum, Facilitates Erythrocyte Invasion. PLOS Pathogens (2006).
5. The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site. Malaria Journal (2019).
6. Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum. PLOS ONE (2009).